Discovery Biology Solutions

With comprehensive expertise in biology, Aragen delivers high-quality, seamless, and cost-effective solutions across the pharmaceutical and biotechnology value chain. The biological evaluation of New Molecular Entities (NMEs) is central to understanding structure–activity relationships, potency, selectivity, druggability, and both in vitro and in vivo efficacy.

Our capabilities span cell and protein sciences, high-throughput screening, assay development, biomarker validation, radiometric assays, DMPK, animal pharmacology using disease models, and exploratory toxicology — supporting programs for both small molecules and biologics.